in order to investigate the efficacy and tolerance of trastuzumab in combination with paclitaxel and carboplatin in patients with HER2-positive (fluorescence in situ hybridization [FISH] positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback